FDA Inspection 1250167 — Emergent Clinical Consulting, LLC
The FDA completed an inspection of Emergent Clinical Consulting, LLC on Sep 10, 2024 in Trappe, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 10, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Trappe, PA (United States)
Additional Details
Sponsor, Contract Research Organization